Login Register Cart 0
Generic placeholder image

Current Psychopharmacology

Editor-in-Chief

ISSN (Print): 2211-5560
ISSN (Online): 2211-5579

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Biography

Meet Our Editor-in-Chief

Author(s): Kenneth Blum

Volume 10, Issue 1, 2021

Published on: 25 January, 2021

Page: [3 - 3] Pages: 1

DOI: 10.2174/221155601001210125124530

[1]
Swenson S, Blum K, McLaughlin T, Gold MS, Thanos PK. The therapeutic potential of exercise for neuropsychiatric diseases: A review. J Neurol Sci 2020 May 15; 412116763 Epub 2020 Mar 4
[http://dx.doi.org/10.1016/j.jns.2020.116763] [PMID: 32305746]
[2]
Blum K, Cadet JL, Baron D, et al. Putative COVID- 19 Induction of Reward Deficiency Syndrome (RDS) and Associated Behavioral Addictions with Potential Concomitant Dopamine Depletion: Is COVID-19 Social Distancing a Double Edged Sword? Subst Use Misuse 2020; 55(14): 2438-42. Epub 2020 Sep 22
[http://dx.doi.org/10.1080/10826084.2020.1817086] [PMID: 32957797]
[3]
Gondré-Lewis MC, Bassey R, Blum K. Pre-clinical models of reward deficiency syndrome: A behavioral octopus. Neurosci Biobehav Rev 2020; 115: 164-88. Epub 2020 Apr 28
[http://dx.doi.org/10.1016/j.neubiorev.2020.04.021] [PMID: 32360413] [PMCID: PMC7594013]
[4]
Fried L, Modestino EJ, Siwicki D, et al. Hypodopaminergia and Precision Behavioral Management (PBM): It is a Generational Family Affair. Curr Pharm Biotechnol 2020; 21(6): 528-41.
[http://dx.doi.org/10.2174/1389201021666191210112108] [PMID: 31820688]
[5]
Blum K, Cadet JL, Gold MS. Psychostimulant use disorder emphasizing methamphetamine and the opioid -dopamine connection: Digging out of a hypodopaminergic ditch. J Neurol Sci 2020 Nov 28; 420117252 Epub ahead of print
[http://dx.doi.org/10.1016/j.jns.2020.117252] [PMID: 33279726]
[6]
Gold MS, Baron D, Bowirrat A, Blum K. Neurological correlates of brain reward circuitry linked to opioid use disorder (OUD): Do homo sapiens acquire or have a reward deficiency syndrome? J Neurol Sci 2020 Nov 15; 418117137 Epub 2020 Sep 15
[http://dx.doi.org/10.1016/j.jns.2020.117137] [PMID: 32957037] [PMCID: PMC7490287]
[7]
Blum K, Lott L, Baron D, Smith DE, Badgaiyan RD, Gold MS. Improving naltrexone compliance and outcomes with putative pro- dopamine regulator KB220, compared to treatment as usual J Syst Integr Neurosci 2020 May 30; 7
[http://dx.doi.org/10.15761/JSIN.1000229] [PMID: 32934823] [PMCID: PMC7489288]
[8]
Abijo T, Blum K, Gondré-Lewis MC. Neuropharmacological and Neurogenetic Correlates of Opioid Use Disorder (OUD) As a Function of Ethnicity: Relevance to Precision Addiction Medicine. Curr Neuropharmacol 2020; 18(7): 578-95.
[http://dx.doi.org/10.2174/1570159X17666191118125702] [PMID: 31744450] [PMCID: PMC7457418]
[9]
Blum K, Baron D, McLaughlin T, Gold MS. Molecular neurological correlates of endorphinergic/dopaminergic mechanisms in reward circuitry linked to endorphinergic deficiency syndrome (EDS). J Neurol Sci 2020; 411116733 Epub 2020 Feb 14
[http://dx.doi.org/10.1016/j.jns.2020.116733] [PMID: 32088516]
[10]
Kotyuk E, Magi A, Eisinger A, et al. Co-occurrences of substance use and other potentially addictive behaviors: Epidemiological results from the Psychological and Genetic Factors of the Addictive Behaviors (PGA) Study. J Behav Addict 2020 Jun 26; 9(2): 272-88.
[http://dx.doi.org/10.1556/2006.2020.00033] [PMID: 32609628]
[11]
Blum K, Baron D, Lott L, et al. In Search of Reward Deficiency Syndrome (RDS)-free Controls: The “Holy Grail” in Genetic Addiction Risk Testing. Curr Psychopharmacol 2020; 9(1): 7-21.
[PMID: 32432025] [PMCID: PMC7236426]
[12]
Downs BW, Blum K, Bagchi D, et al. Molecular neuro-biological and systemic health benefits of achieving dopamine homeostasis in the face of a catastrophic pandemic (COVID- 19): A mechanistic exploration. J Syst Integr Neurosci 2020 Apr 30; 7: -.
[http://dx.doi.org/10.15761/JSIN.1000228] [PMID: 32934824] [PMCID: PMC7489293]
[13]
Blum K, Gondré-Lewis MC, Modestino EJ, et al. Understanding the Scientific Basis of Post-traumatic Stress Disorder (PTSD): Precision Behavioral Management Overrides Stigmatization. Mol Neurobiol 2019 Nov; 56(11): 7836-50. Epub 2019 May 23
[http://dx.doi.org/10.1007/s12035-019-1600-8] [PMID: 31124077] [PMCID: PMC6815696]
[14]
Baron D, Blum K, Chen A, Gold M, Badgaiyan RD. Conceptualizing Addiction From an Osteopathic Perspective: Dopamine Homeostasis. J Am Osteopath Assoc 2018; 118(2): 115-8.
[http://dx.doi.org/10.7556/jaoa.2018.026] [PMID: 29379966]
[15]
Blum K, Han D, Modestino EJ, et al. A Systematic, Intensive Statistical Investigation of Data from the Comprehensive Analysis of Reported Drugs (CARD) for Compliance and Illicit Opioid Abstinence in Substance Addiction Treatment with Buprenorphine/naloxone. Subst Use Misuse 2018 Jan 28; 53(2): 220-9. Epub 2017 Dec 19
[http://dx.doi.org/10.1080/10826084.2017.1400064] [PMID: 29257919]
[16]
Blum K, Gondré-Lewis MC, Baron D, et al. Introducing Precision Addiction Management of Reward Deficiency Syndrome, the Construct That Underpins All Addictive Behaviors. Front Psychiatry 2018 Nov 7; 9: 548.
[http://dx.doi.org/10.3389/fpsyt.2018.00548] [PMID: 30542299] [PMCID: PMC6277779]

Rights & Permissions Print Cite
Article Metrics
10
© 2024 Bentham Science Publishers | Privacy Policy